mHIVE World AIDS Day 2019

                     


mHIVE World AIDS Day 2019 Symposium 


This year's mHIVE Symposium will be held on Friday 29th November 2019 at the Peter Doherty Institute
focused on:

Harnessing Antibodies for HIV Prevention, Treatment
and Cure

mHIVE World AIDS Day Symposium is proudly organised in partnership with the

Keynote Speaker: A/Prof Marina Caskey (Rockerfeller University)

Clinical Perspective: Dr James McMahon (Monash University, Alfred Health)

Community forum: Community experiences participating in clinical trials

Panel: Heather Magawgwa, Craig Burnett, Dr Thomas Rasmussen, Dr Jillian Lau

Moderated by Dr Miranda Smith


Early career investigator oral and poster presentations


Click here to register for the event


Invited Speakers


 

ASSOCIATE PROFESSOR MARINA CASKEY

Laboratory of Molecular Immunology, The Rockefeller University

 

A/Prof Caskey’s work focuses on the development and clinical evaluation of novel immunotherapeutic strategies against infectious diseases, with a special emphasis on HIV.

 

Over the last four years, Caskey has led a series of first-in-human studies with two of the most promising broadly neutralizing anti-HIV-1 antibodies: 3BNC117 and 10-1074, which were isolated from HIV-infected individuals by the Laboratory of Molecular Immunology. These first studies aim to evaluate the safety, pharmacokinetics, and antiviral activity of these molecules in both HIV-infected and HIV-uninfected individuals. In addition to controlling viral replication and preventing infection by blocking viral entry, these molecules have the potential to interfere with the latent reservoir of infected cells that is not eliminated by standard treatment.

 

Studies of neutralizing antibodies, in combination with other immunologic strategies directed toward achieving HIV cure or long-term remission, are also being pursued by Caskey’s team. These initial studies, conducted at The Rockefeller University Hospital, have begun to elucidate the in vivo activity of these molecules in humans and have generated supportive data to advance their development to larger clinical studies with the goal of determining their efficacy in preventing HIV infection in high-risk populations.

 
 

DOCTOR JAMES McMAHON

Infectious Diseases Physician, Alfred Hospital and Monash University

Dr McMahon is an Infectious Diseases physician and Head of Clinical Research at the Alfred Hospital and Monash University, and an Infectious Diseases Physician at Monash Medical Centre.

 

Dr McMahon is an NHMRC Early Career Fellow, Chairs the Antiretroviral Guidelines Committee for the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) and sits on the ASHM Board. His research interests are in clinical trials focused on HIV Cure and antiretroviral therapy. Specific interests include developing non-invasive imaging methods to locate and quantify tissue sites of HIV and clinical trials of interventions targeting the HIV reservoir including latency reversal agents and agents to increase HIV-specific immune responses.

 
 

CRAIG BURNETT

Living Positive Victoria

Craig is currently the senior policy and research officer for Living Positive Victoria; the chair of the community advisory board for the Melbourne HIV Cure Consortium; and a member of the ARV guidelines committee. In the past, Craig has served on the board of Thorne Harbour Health (formerly the Victorian AIDS Council) and has attended the past three international AIDS conferences; focusing on the science streams. Craig still maintains a strong connection with the positive community by organising events for The Institute of Many and facilitating Gen Next; a youth group for people living with HIV in Victoria.

 
 

DOCTOR JILLIAN LAU

Infectious Diseases Physician & Clinical Research Fellow, Alfred Hospital

 

Jillian Lau is an Infectious Diseases physician and clinical research fellow at the Alfred Hospital. She is involved in designing clinical trials in HIV cure research, and has recruited, enrolled and cared for volunteers in various studies. She is completing a PhD in social and clinical studies towards a cure for HIV.

 
 

DOCTOR THOMAS RASMUSSEN

Clinical Research Fellow, Peter Doherty Institute

 

Dr Thomas Rasmussen is a Clinical Research Fellow in Professor Sharon Lewin’s laboratory. Thomas has a Doctor of Medicine degree from Aarhus University, Denmark in 2006 and has since been involved in clinical infectious disease medicine and HIV-related science with research activities primarily including clinical, translational and epidemiological studies. He completed his PhD in HIV in 2014, which was focused on the clinical use of histone deacetylase inhibitors to reverse HIV-1 latency. Thomas’ ongoing research is focused at understanding the barriers to curing HIV-1 infection and testing new strategies aimed at eliminating latent HIV-1 infection.

 
 

DOCTOR MIRANDA SMITH

Project Officer - Australian Partnership (for) Preparedness Research on Infectious (disease) Emergencies (APPRISE), Peter Doherty Institute

 

Dr Miranda Smith is passionate about scientific communication and evidence-based public health interventions. She is the Project Officer for the Australian Partnership (for) Preparedness Research on Infectious (disease) Emergencies (APPRISE), and part of the HIV Cure Community Partnership. Miranda has a background in laboratory research, with a PhD in immunology from The University of Melbourne, and postdoctoral experience in basic and clinical HIV research at the ETH in Zurich, Switzerland and at Monash University. She also holds a Masters in Public Health from Monash University, and has worked as a medical writer, including for the website hivcure.com.au.







VENUE FOR ALL EVENTS: Peter Doherty Institute for Infection and Immunity, 792 Elizabeth St, Melbourne VIC 3000


The Peter Doherty Institute for Infection and Immunity



The 2019 mHIVE WAD program is sponsored by:

 https://www.viivhealthcare.com/ 
http://www.gilead.com/
 

  

The 2019 mHIVE WAD program is supported by our symposium partners:

https://livingpositivevictoria.org.au/



Previous World AIDS Days

mHIVE World AIDS Day Symposium 2018
Theme:
HIV, Ageing and Co-morbidities: The Challenges of Living with Chronic HIV

Visit the symposium website 2018 for details about our previous mHIVE World AIDS Day symposium:

mHIVE World AIDS Day Symposium 2017
Theme: HIV Prevention - Past and Future Challenges

Visit the symposium website 2017 for details about our previous mHIVE World AIDS Day symposium:


mHIVE World AIDS Day Symposium 2016
Theme: Women and HIV 
We were proud to host Jo-Ann Passmore (University of Cape Town) as our prestigious invited speaker the mHIVE  World AIDS Day Symposium 2016Assoc Prof Jo-Ann Passmore's research has focused on studying genital tract adaptive and innate immune responses associated with protection from or susceptibility to sexually transmitted viral diseases including HPV and HIV. She is specifically interested in studying biomarkers for susceptibility and protection to HIV infection, including secreted inflammatory molecules, genital immune activation and HIV-specific immune responses present in the female genital tract. See the mHIVE WAD 2016 program here.

Visit the symposium website 2016 for details about our previous mHIVE World AIDS Day symposium:

mHIVE World AIDS Day Symposium 2015
Inaugural mHIVE World AIDS Day Symposium
We were proud to host Jacob Estes (Principal Scientist, Retroviral Immunopathology Section Head, Tissue Analysis Core, Frederick National Laboratory for Cancer Research) as our prestigious keynote speaker in 2015. Dr Jacob Estes also generously contributed his time and conducted a free three day RNAscope workshop and Seminar. See the mHIVE WAD 2015 program here.









Subpages (1): WAD 2019 Programme
Comments